APA (7th ed.) Citation

Dirven, I., De Vita, E., Vounckx, M., Kessels, J., Mandalà, M., & Neyns, B. (2024). 1132P Regorafenib in Caucasian patients with pretreated advanced KIT-mutant melanoma: A dual center case series. Annals of Oncology, 35, S743. https://doi.org/10.1016/j.annonc.2024.08.2135

Chicago Style (17th ed.) Citation

Dirven, I., E. De Vita, M. Vounckx, J.I Kessels, M. Mandalà, and B. Neyns. "1132P Regorafenib in Caucasian Patients with Pretreated Advanced KIT-mutant Melanoma: A Dual Center Case Series." Annals of Oncology 35 (2024): S743. https://doi.org/10.1016/j.annonc.2024.08.2135.

MLA (9th ed.) Citation

Dirven, I., et al. "1132P Regorafenib in Caucasian Patients with Pretreated Advanced KIT-mutant Melanoma: A Dual Center Case Series." Annals of Oncology, vol. 35, 2024, p. S743, https://doi.org/10.1016/j.annonc.2024.08.2135.